Theravance Biopharma, Inc. (TBPH)
17.55
-0.22
(-1.24%)
USD |
NASDAQ |
Dec 16, 16:00
17.55
0.00 (0.00%)
After-Hours: 16:45
Theravance Biopharma Gross Profit (Annual): 58.37M for Dec. 31, 2024
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Corcept Therapeutics, Inc. | 664.16M |
| Assertio Holdings, Inc. | 59.89M |
| Skye Bioscience, Inc. | -0.2986M |
| FibroGen, Inc. | 14.06M |
| VYNE Therapeutics, Inc. | 0.497M |